Lakjaya Buluwela

6PUBLICATIONS
40CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
Author Correction: Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cells.

|Sep 08, 2025
Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cells.

Chun-Fui Lai, Victoria I Cushing, Ellen Olden

|Aug 15, 2025
TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer.

Nuno Padrão, Sebastian Gregoricchio, Nils Eickhoff

|Oct 02, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.

Carolina Gemma, Chun-Fui Lai, Anup K Singh

|Oct 05, 2022
Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer.

Alison Harrod, Chun-Fui Lai, Isabella Goldsbrough

|Apr 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation.

Zheqi Li, Olivia McGinn, Yang Wu

Pageof 1

Frequent Collaborators

5 joint publications

Simak Ali

4 joint publications

R Charles Coombes

3 joint publications

Chun-Fui Lai

2 joint publications

Basil J Greber